The growth of Viagra and its impact on the medicinal landscape presents a complex question for shareholders. While the initial sales data were remarkable, the exclusivity has lapsed, leading to a wave of copycat https://alvinrspa370932.dailyblogzz.com/41867914/the-blue-pill-and-pharma-a-risky-opportunity